Inhalable Biologics, Gene Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15,000
NCT02253251
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2014
Completion: Sep 30, 2035
Loading map...